[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354270-105":59,"doc-detail-354270-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","prevalence-of-cancer-survivors-in-2019-among-patients-diagnosed-between-1975-and-2019-a-population-based-study-in-japan","Prevalence of Cancer Survivors in 2019 Among Patients Diagnosed Between 1975 and 2019: A Population-Based Study in Japan","","Owing to improved prognosis, cancer survivors are a growing population; however, little is known about their prevalence in Asian countries. This study estimated the prevalence and characteristics of cancer survivors in Japan, including long-term survivors. Using Osaka Cancer Registry data covering 8.8 million residents, it identified individuals diagnosed between 1975 and 2019 who were alive in 2019. Prevalence was stratified by sex, age, time since diagnosis, and 22 cancer types, and national estimates were derived from Osaka proportions.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prevalence-of-cancer-survivors-in-2019-among-patients-diagnosed-between-1975-and-2019-a-population-based-study-in-japan/354270/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prevalence-of-cancer-survivors-in-2019-among-patients-diagnosed-between-1975-and-2019-a-population-based-study-in-japan/354270.png","ImageObject",300,407,{"name":92,"@type":93},"Dipper","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-12","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How was cancer survivor prevalence in Japan estimated for 2019?","Question",{"text":113,"@type":114},"The study used data from the Osaka Cancer Registry to identify individuals diagnosed between 1975 and 2019 who were alive in 2019. Prevalence was stratified by sex, age, time since diagnosis, and 22 cancer types, then national estimates were obtained by applying Osaka sex- and age-specific proportions to Japan.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What proportion of cancer survivors in 2019 were long-term survivors?",{"text":118,"@type":114},"Long-term survivors were defined as those diagnosed at least 10 years earlier. They comprised 34% of all cancer survivors in 2019.",{"name":120,"@type":111,"acceptedAnswer":121},"What major distribution pattern by age and sex was reported for 2019 survivors in Osaka?",{"text":122,"@type":114},"Most survivors were older adults, with 83% of males (188,881) and 70% of females (163,331) aged 65 years or older in 2019.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},354270,1790231065,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Cancer Medicine  \nRESEARCH ARTICLE  OPEN ACCESS   \nPrevalence of Cancer Survivors in 2019 Among Patients Diagnosed Between 1975 and 2019: A Population-Based Study in Japan  \nHaruka Kudo | Kayo Nakata | Kenji Kishimoto | Toshiki Ikawa | Yoko Iwaki | Yoshihiro Kuwabara | Toshitaka Morishima  | Isao Miyashiro  \nCancer Control Center, Osaka International Cancer Institute, Osaka, Japan  \nCorrespondence: Haruka Kudo ([hkudo@oici.jp](hkudo@oici.jp))  \nReceived: 13 May 2026 | Revised: 27 May 2026 | Accepted: 29 May 2026  \nKeywords: cancer registry | cancer survivors | population-based study | prevalence  \nABSTRACT  \nOwing to improved prognosis, cancer survivors are a growing population; however, little is known about their prevalence in Asian countries. This study estimated the prevalence and characteristics of cancer survivors in Japan, including long-term survivors. Using data from the Osaka Cancer Registry, which covers 8.8 million residents in Osaka Prefecture, Japan, we identified individuals diagnosed with cancer between 1975 and 2019 who were alive in 2019. Cancer prevalence was calculated as the number of patients alive in 2019, stratified by sex, age in 2019, time since diagnosis, and 22 cancer types. National estimates were obtained by applying sex-and age-specific prevalence proportions in Osaka to the Japanese population. In 2019, 461,489 cancer survivors were living in Osaka Prefecture (5.4% of the prefectural population; 5221 per 100,000). Most were older adults, with 83% of males (n = 188,881) and 70% of females (n = 163,331) aged ≥65years in 2019. Long-term survivors (≥10years after diagnosis) comprised 34% of all survivors. These patterns varied across cancer types. Nationally, an estimated 6.9 million individuals (5.5% of the national population) lived after a cancer diagnosis. Based on 44 years of follow-up data, our findings highlighted a substantial subgroup of cancer survivors requiring long-term treatment, follow-up care, and age-specific support. These findings may provide useful insights for healthcare planning and cancer survivor policies in aging societies.  \n1 | Introduction  \nThe incidence of cancer is increasing worldwide. In Japan, approximately 0.85 million cancers were diagnosed in 2011, increasing to 0.99 million by 2021 [1, 2]. The prognosis of patients with cancer has improved, with the 5-year relative survival for all cancer sites rising from 54.3% in 1997–1999 to 64.1% by 2009– 2011 [3, 4] . Cancer survivors require comprehensive, long-term support including follow-up medical care, rehabilitation, and monitoring for late effects, which often differ from the resources needed for the treatment of patients with newly diagnosed cancers [5] .  \nThe number of people who have experienced cancer at a specified point in time, known as cancer prevalence, is a useful measure for planning survivorship care. In 2020, the estimated number of individuals living after a cancer diagnosis was 23.7 million in Europe [6], rising by approximately 3% per year in Italy [7] . In the United States (US), the estimated number of cancer survivors was 13.7 million in 2012, and was projected to reach 18.0 million by 2020 [8]. Moreover, approximately 40% of all prevalent individuals had survived > 10 years after a cancer diagnosis [6, 8] .  \nAsian countries may have distinct patterns in the prevalence of cancer survivors owing to differences in population  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.  \n© 2026 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.  \nCancer Medicine, 2026; 15:e72012 1 of 13  \n[https://doi.org/10.1002/cam4.72012](https://doi.org/10.1002/cam4.72012)  \ncharacteristics, cancer epidemiology, and distribution of cancer types. For example, the incidence of stomach cancer remains subs","cbCaihfDjdIuRJef","https://ap.wps.com/l/cbCaihfDjdIuRJef","pdf",1003196,13,"English","# Introduction\n# Material and Methods\n## Data Source and Study Cohort","[{\"question\":\"How was cancer survivor prevalence in Japan estimated for 2019?\",\"answer\":\"The study used data from the Osaka Cancer Registry to identify individuals diagnosed between 1975 and 2019 who were alive in 2019. Prevalence was stratified by sex, age, time since diagnosis, and 22 cancer types, then national estimates were obtained by applying Osaka sex- and age-specific proportions to Japan.\"},{\"question\":\"What proportion of cancer survivors in 2019 were long-term survivors?\",\"answer\":\"Long-term survivors were defined as those diagnosed at least 10 years earlier. They comprised 34% of all cancer survivors in 2019.\"},{\"question\":\"What major distribution pattern by age and sex was reported for 2019 survivors in Osaka?\",\"answer\":\"Most survivors were older adults, with 83% of males (188,881) and 70% of females (163,331) aged 65 years or older in 2019.\"}]","Prevalence of Cancer Survivors in 2019 Among Patients Diagnosed Between 1975 and 2019: A Population-Based Study in Japan | PDF",1790109797,33,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f03efbb2e3abc985f9a9ecfbebb8da62.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d597278db6eed0dcc5afcf7afd9ea7d9.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e542727c811caafb6ea5c0d94aca31f5.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f56e96182311119515ea19930a00b24.webp",980,1287]